06.22.20
Eevia Health Oy, a company specializing in plant extracts sourced from arctic forests, including lingonberries, bilberries, and other plant and fungus material, will be stepping up production of its new elderberry extract, Feno-Sambucus 14, to meet the robust increase in demand for elderberry products.
Elderberries grow quite widely in Europe, and the overall order volume for Elderberries is currently over 2 million euros. Additionally, and despite the fact that no proven treatment or prevention for COVID-19 exists to date, there has been an unprecedented surge in demand for several other vitamins, minerals, herbs, and other extracts over the past several months, in which frenzied buyers have stocked up on natural remedies of all sorts. In fact, one fifth of the items sold on Amazon in April of this year contained elderberry.
Elderberry is one of the most commonly-used medicinal plants in the world, with its usage spanning thousands of years. In addition to being rich in vitamins, antioxidants, flavonols, and anthocyanins, small preliminary trials have found that they may shorten the duration of cold and flu symptoms.
The current challenge the elderberry industry is facing right now has mostly to do with shortages of raw material to serve all orders, Eevia said in a statement, indicating that the company will be working to ensure demand can be met.
“We have spent years specializing in arctic bilberries and more typical species in the north, and look forward to adding our expertise to the robust elderberry market with the introduction of Feno-Sambucus 14,” Anna-Maija Vanhatalo, Eevia Health Oy sales manager, said. “We extract for the same bioactive in elderberries, the anthocyanins, as we do in bilberries. It is, therefore, a very straightforward business for us to undertake this new product. We have demand for extracts from elderberry for several million euros and we have temporarily accepted only a smaller fraction of these orders while we work to increase our production. We believe that the elderberry carries the potential to be another backbone to our business, joining the lingonberry, bilberry, and other berry extracts.”
Elderberries grow quite widely in Europe, and the overall order volume for Elderberries is currently over 2 million euros. Additionally, and despite the fact that no proven treatment or prevention for COVID-19 exists to date, there has been an unprecedented surge in demand for several other vitamins, minerals, herbs, and other extracts over the past several months, in which frenzied buyers have stocked up on natural remedies of all sorts. In fact, one fifth of the items sold on Amazon in April of this year contained elderberry.
Elderberry is one of the most commonly-used medicinal plants in the world, with its usage spanning thousands of years. In addition to being rich in vitamins, antioxidants, flavonols, and anthocyanins, small preliminary trials have found that they may shorten the duration of cold and flu symptoms.
The current challenge the elderberry industry is facing right now has mostly to do with shortages of raw material to serve all orders, Eevia said in a statement, indicating that the company will be working to ensure demand can be met.
“We have spent years specializing in arctic bilberries and more typical species in the north, and look forward to adding our expertise to the robust elderberry market with the introduction of Feno-Sambucus 14,” Anna-Maija Vanhatalo, Eevia Health Oy sales manager, said. “We extract for the same bioactive in elderberries, the anthocyanins, as we do in bilberries. It is, therefore, a very straightforward business for us to undertake this new product. We have demand for extracts from elderberry for several million euros and we have temporarily accepted only a smaller fraction of these orders while we work to increase our production. We believe that the elderberry carries the potential to be another backbone to our business, joining the lingonberry, bilberry, and other berry extracts.”